Form 4: Guardant Health Director Exercises Stock Options

Sentiment:

SEC Form 4 Filing


Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on August 4, 2024, acquiring 66 shares of common stock.

Summary

  • On August 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., exercised stock options.
  • This transaction resulted in the acquisition of 66 shares of common stock at a price of $0.
  • Following the transaction, Joyce directly owns 10,345 shares of Guardant Health common stock.
  • The filing also details the vesting schedule of restricted stock units, with 25% vesting on August 4, 2022, and the remaining 75% vesting in monthly installments over three years.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into the director's stock ownership.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers. These filings are closely watched by investors as they can provide insights into management's views on the company's prospects.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
08/04/202225% of restricted stock units vested
08/04/2024Director exercised stock options and acquired 66 shares
08/05/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.